Invest on your own
Build your own portfolio, stock by stock.
We do it for you
Professionally managed portfolios, built and rebalanced for you.
NEW
How we screen every stock
Our halal screening & purification process in 3 minutes
Screeners
Your portfolio
Calculators
TOOL
Check any stock in seconds
Search 11,000+ tickers and see the halal verdict instantly.
Our certifications
Independent proof that every stock and portfolio meets halal standards.
METHODOLOGY
How we screen every stock
Our 5-step halal methodology, in 90 seconds.
Get help
NEW
Halal investing 101
A beginner-friendly intro to investing the halal way.
Plans by product
COMPARE
Find your plan
See every feature side-by-side and pick what fits.
Investors
INVESTORS
Invest in Musaffa
We're building the financial house for 1.9B Muslims. See the deck.
CYDY Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: January 13, 2025
Report Source: 2025 1st Quarter Report
Cytodyn Inc. Stock Analysis CYDY
United States Health Care Small Cap Report: CytoDyn, Inc. is a clinical-stage biotechnology company, which focuses on the clinical development of innovative treatments for multiple therapeutic indications based on its product candidate, leronlimab, a novel humanized monoclonal antibody targeting the C-C chemokine receptor type 5. The company is headquartered in Vancouver Washington, Washington and currently employs 13 full-time employees. The company went IPO on 2005-11-17. The firm is focused on the development and commercialization of leronlimab, an investigational humanized IgG4 monoclonal antibody (mAb) that is designed to bind to C-C chemokine receptor type 5 (CCR5), a protein on the surface of certain immune system cells. The company has studied leronlimab in multiple therapeutic areas, including infectious disease, oncology, and autoimmune conditions. The firm has conducted clinical trials of leronlimab as a viral entry inhibitor for human immunodeficiency virus (HIV), believed to competitively bind to the N-terminus and second extracellular loop of the CCR5 receptor. For immunology, the CCR5 receptor is believed to be implicated in immune-mediated illnesses, such as metabolic dysfunction-associated steatohepatitis. The company has a joint development agreement with a third-party generative artificial intelligence (AI) drug discovery and development company to develop one or more longer-acting molecules.
Read More Cytodyn Inc (CYDY) Chart
Key Statistics of Cytodyn Inc (CYDY)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.26Volume
1.66MP/E Ratio (TTM)
96.3252 Week Range
Market Cap
476.06MAvg. Volume
1.76MDividend Yield
-Financial Metrics & Statements of Cytodyn Inc (CYDY)
FAQ's for Cytodyn Inc (CYDY)
- According to Musaffa’s Shariah screening methodology, Cytodyn Inc (CYDY) is currently classified as NOT HALAL as of January 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Cytodyn Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Cytodyn Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Cytodyn Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Cytodyn Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Cytodyn Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.